financetom
Business
financetom
/
Business
/
Apple says some AI improvements to Siri delayed to 2026
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Apple says some AI improvements to Siri delayed to 2026
Mar 7, 2025 10:06 AM

(Reuters) - Some artificial intelligence improvements to Apple's ( AAPL ) voice assistant Siri will be delayed until 2026, the company said on Friday.

In a statement, Apple ( AAPL ) said it has "been working on a more personalized Siri, giving it more awareness of your personal context, as well as the ability to take action for you within and across your apps. It's going to take us longer than we thought to deliver on these features and we anticipate rolling them out in the coming year."

Apple ( AAPL ) did not give a reason for the delays. The iPhone maker had previously indicated the features would come in 2025.

Last year, Apple ( AAPL ) announced a range of AI-driven features called Apple Intelligence that included new capabilities such as rewriting emails and summarizing a cluttered inbox.

Some of the biggest improvements were aimed at giving its Siri assistant the ability to duck in and out of apps and complete tasks for a user by tapping into information stored on Apple ( AAPL ) devices.

Apple ( AAPL ) gave examples such as asking Siri to pull up a podcast recommended by a friend or pulling up flight tracking information from a relative, all based on data held on the device.

The company has been building a vast new cloud computing infrastructure that runs on its own chips in an effort to maintain its privacy stance while delivering AI features. Apple ( AAPL ) has said Siri fields 1.5 billion user requests per day.

Apple's ( AAPL ) rivals have also been rushing to add AI features to their voice assistants, with Alphabet's Google adding its Gemini model to its assistant last year.

Amazon ( AMZN ) last month rolled out an AI-driven overhaul of its Alexa assistant, saying that the new capabilities would be free for subscribers to its Prime program but cost $19.99 a month otherwise.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Gucci-owner Kering posts 10% drop in Q1 sales on sluggish Chinese demand
Gucci-owner Kering posts 10% drop in Q1 sales on sluggish Chinese demand
Apr 23, 2024
PARIS (Reuters) -French luxury group Kering reported a 10% drop in first-quarter sales on Tuesday, dragged down by a slowdown at its star label Gucci, which suffered from weakness in Asia while undergoing a design overhaul. The group said its first half operating profit would be sharply lower due to the revenue decline and its ongoing investment in its brands....
MultiMetaVerse Gets Noncompliance Notices From Nasdaq
MultiMetaVerse Gets Noncompliance Notices From Nasdaq
Apr 23, 2024
12:00 PM EDT, 04/23/2024 (MT Newswires) -- MultiMetaVerse Holdings ( MMV ) said Tuesday that Nasdaq has notified the company of its noncompliance with the exchange's rules on minimum bid price and minimum market value of listed securities. The company said it has until Oct. 14 to regain compliance with Nasdaq's rules. The company's shares were up more than 4%...
Why AI-Powered Vehicle Supplier Cyngn's Stock Is Driving Higher
Why AI-Powered Vehicle Supplier Cyngn's Stock Is Driving Higher
Apr 23, 2024
Cyngn Inc. ( CYN ) shares are trading higher Tuesday after the company announced that it has been chosen to supply its DriveMod Tuggers for industrial automation to John Deere’s operation in Dubuque, Iowa. The Details: “We are thrilled to be working with Deere, a company that has a long history of producing cutting-edge technology that yields amazing products for...
Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says
Bausch Health in 'Stronger Position' for Bausch + Lomb Distribution, RBC Says
Apr 23, 2024
12:04 PM EDT, 04/23/2024 (MT Newswires) -- Bausch Health ( BHC ) is in a stronger position to proceed with a Bausch + Lomb (BLCO) distribution to its shareholders following a recent appellate court ruling that prevents the Food and Drug Administration from approving a generic version of Bausch's diarrhea treatment Xifaxan until 2029, RBC Capital Markets said in a...
Copyright 2023-2026 - www.financetom.com All Rights Reserved